143 related articles for article (PubMed ID: 21491092)
1. Antitumor effects of the combination of cholesterol reducing drugs.
Issat T; Nowis D; Bil J; Winiarska M; Jakobisiak M; Golab J
Oncol Rep; 2011 Jul; 26(1):169-76. PubMed ID: 21491092
[TBL] [Abstract][Full Text] [Related]
2. Berberine, a natural cholesterol reducing product, exerts antitumor cytostatic/cytotoxic effects independently from the mevalonate pathway.
Issat T; Jakóbisiak M; Golab J
Oncol Rep; 2006 Dec; 16(6):1273-6. PubMed ID: 17089049
[TBL] [Abstract][Full Text] [Related]
3. Apomine enhances the antitumor effects of lovastatin on myeloma cells by down-regulating 3-hydroxy-3-methylglutaryl-coenzyme A reductase.
Roelofs AJ; Edwards CM; Russell RG; Ebetino FH; Rogers MJ; Hulley PA
J Pharmacol Exp Ther; 2007 Jul; 322(1):228-35. PubMed ID: 17412884
[TBL] [Abstract][Full Text] [Related]
4. Studies of the isoprenoid-mediated inhibition of mevalonate synthesis applied to cancer chemotherapy and chemoprevention.
Mo H; Elson CE
Exp Biol Med (Maywood); 2004 Jul; 229(7):567-85. PubMed ID: 15229351
[TBL] [Abstract][Full Text] [Related]
5. Tocotrienols potentiate lovastatin-mediated growth suppression in vitro and in vivo.
McAnally JA; Gupta J; Sodhani S; Bravo L; Mo H
Exp Biol Med (Maywood); 2007 Apr; 232(4):523-31. PubMed ID: 17392488
[TBL] [Abstract][Full Text] [Related]
6. Synergistic inhibitory effect of apomine and lovastatin on osteosarcoma cell growth.
Moriceau G; Roelofs AJ; Brion R; Redini F; Ebetion FH; Rogers MJ; Heymann D
Cancer; 2012 Feb; 118(3):750-60. PubMed ID: 21751201
[TBL] [Abstract][Full Text] [Related]
7. Statins inhibit blastocyst formation by preventing geranylgeranylation.
Alarcon VB; Marikawa Y
Mol Hum Reprod; 2016 May; 22(5):350-63. PubMed ID: 26908642
[TBL] [Abstract][Full Text] [Related]
8. Lovastatin-induced proliferation inhibition and apoptosis in C6 glial cells.
Choi JW; Jung SE
J Pharmacol Exp Ther; 1999 Apr; 289(1):572-9. PubMed ID: 10087052
[TBL] [Abstract][Full Text] [Related]
9. Reduction of mouse mammary tumor formation and metastasis by lovastatin, an inhibitor of the mevalonate pathway of cholesterol synthesis.
Alonso DF; Farina HG; Skilton G; Gabri MR; De Lorenzo MS; Gomez DE
Breast Cancer Res Treat; 1998 Jul; 50(1):83-93. PubMed ID: 9802623
[TBL] [Abstract][Full Text] [Related]
10. [The anticancer properties of statins].
Sławińska A; Kandefer-Szerszeń M
Postepy Hig Med Dosw (Online); 2008 Aug; 62():393-404. PubMed ID: 18688209
[TBL] [Abstract][Full Text] [Related]
11. Differential sensitivity of various pediatric cancers and squamous cell carcinomas to lovastatin-induced apoptosis: therapeutic implications.
Dimitroulakos J; Ye LY; Benzaquen M; Moore MJ; Kamel-Reid S; Freedman MH; Yeger H; Penn LZ
Clin Cancer Res; 2001 Jan; 7(1):158-67. PubMed ID: 11205904
[TBL] [Abstract][Full Text] [Related]
12. In vitro myotoxicity of the 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors, pravastatin, lovastatin, and simvastatin, using neonatal rat skeletal myocytes.
Masters BA; Palmoski MJ; Flint OP; Gregg RE; Wang-Iverson D; Durham SK
Toxicol Appl Pharmacol; 1995 Mar; 131(1):163-74. PubMed ID: 7878672
[TBL] [Abstract][Full Text] [Related]
13. Ciglitazone, an agonist of peroxisome proliferator-activated receptor gamma, exerts potentiated cytostatic/cytotoxic effects against tumor cells when combined with lovastatin.
Mrówka P; Glodkowska E; Nowis D; Legat M; Issat T; Makowski M; Szokalska A; Janowska S; Stoklosa T; Jakóbisiak M; Golab J
Int J Oncol; 2008 Jan; 32(1):249-55. PubMed ID: 18097565
[TBL] [Abstract][Full Text] [Related]
14. Plant-derived monoterpenes suppress hamster kidney cell 3-hydroxy-3-methylglutaryl coenzyme a reductase synthesis at the post-transcriptional level.
Peffley DM; Gayen AK
J Nutr; 2003 Jan; 133(1):38-44. PubMed ID: 12514264
[TBL] [Abstract][Full Text] [Related]
15. Synergism between a novel amphibian oocyte ribonuclease and lovastatin in inducing cytostatic and cytotoxic effects in human lung and pancreatic carcinoma cell lines.
Mikulski SM; Viera A; Darzynkiewicz Z; Shogen K
Br J Cancer; 1992 Aug; 66(2):304-10. PubMed ID: 1503903
[TBL] [Abstract][Full Text] [Related]
16. Potentiated antitumor effects of the combination treatment with statins and pamidronate in vitro and in vivo.
Issat T; Nowis D; Legat M; Makowski M; Klejman MP; Urbanski J; Skierski J; Koronkiewicz M; Stoklosa T; Brzezinska A; Bil J; Gietka J; Jakóbisiak M; Golab J
Int J Oncol; 2007 Jun; 30(6):1413-25. PubMed ID: 17487362
[TBL] [Abstract][Full Text] [Related]
17. Selective induction of apoptosis by HMG-CoA reductase inhibitors in hepatoma cells and dependence on p53 expression.
Kah J; Wüstenberg A; Keller AD; Sirma H; Montalbano R; Ocker M; Volz T; Dandri M; Tiegs G; Sass G
Oncol Rep; 2012 Sep; 28(3):1077-83. PubMed ID: 22710979
[TBL] [Abstract][Full Text] [Related]
18. Tissue-selective acute effects of inhibitors of 3-hydroxy-3-methylglutaryl coenzyme A reductase on cholesterol biosynthesis in lens.
Mosley ST; Kalinowski SS; Schafer BL; Tanaka RD
J Lipid Res; 1989 Sep; 30(9):1411-20. PubMed ID: 2513368
[TBL] [Abstract][Full Text] [Related]
19. Mevalonate prevents lovastatin-induced apoptosis in medulloblastoma cell lines.
Wang W; Macaulay RJ
Can J Neurol Sci; 1999 Nov; 26(4):305-10. PubMed ID: 10563217
[TBL] [Abstract][Full Text] [Related]
20. Proapoptotic and antitumor activities of the HMG-CoA reductase inhibitor, lovastatin, against Dalton's lymphoma ascites tumor in mice.
Ajith TA; Harikumar KB; Thasna H; Sabu MC; Babitha NV
Clin Chim Acta; 2006 Apr; 366(1-2):322-8. PubMed ID: 16380106
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
